Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
4.500
-0.360 (-7.41%)
At close: Jan 8, 2025, 4:00 PM
4.770
+0.270 (6.00%)
After-hours: Jan 8, 2025, 5:44 PM EST
Company Description
Zhengye Biotechnology Holding, through its operating entity, focus on the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock.
For nearly 20 years, the operating entity has been committed to enhancing the health of livestock by offering a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs.
The operating entity’s products are available in 29 provincial regions across China and are exported overseas, to Vietnam, Pakistan, and Egypt.
Zhengye Biotechnology Holding Limited
| Country | China |
| Founded | 2004 |
| IPO Date | Jan 7, 2025 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 286 |
| CEO | Songlin Song |
Contact Details
Address: No.1 Lianmeng Road, Jilin Economic & Technical Development Zone Jilin City, Jilin Province China | |
| Phone | +86-0432-63047008 |
| Website | jlzybio.com |
Stock Details
| Ticker Symbol | ZYBT |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| IPO Price | $4.00 |
| CIK Code | 0001975641 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Zhenfa Han | Director and Chairman of the Board |
| Songlin Song | Chief Executive Officer |
| Wenhua Sun | Director |
| Ping Wang | Chief Financial Officer |
| Zhongyao Liu | Vice General Manager |
| Wei Lian | Vice General Manager |
| Yawen Dong | Vice General Manager |
| Yuyou He | Vice General Manager |
| Wanlin Zhang | Vice General Manager |
| Yuhong Cheng | Vice General Manager |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 8, 2025 | 6-K | Report of foreign issuer |
| Jan 7, 2025 | 424B4 | Prospectus |
| Jan 6, 2025 | CERT | Certification by an exchange approving securities for listing |
| Dec 20, 2024 | EFFECT | Notice of Effectiveness |
| Dec 19, 2024 | 8-A12B | Registration of securities |
| Dec 9, 2024 | POS AM | Post-Effective amendments for registration statement |
| Nov 21, 2024 | FWP | Free Writing Prospectus |
| Nov 15, 2024 | POS AM | Post-Effective amendments for registration statement |
| Sep 30, 2024 | EFFECT | Notice of Effectiveness |
| Sep 18, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |